[A history and prospect of adoptive immunotherapy against malignant glioma--past, now and future].
Nitta
T
T
Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.
D001932:Brain Neoplasms / Q000628:therapy*; D005910:Glioma / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D000922:Immunotoxins / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D008222:Lymphokines / Q000235:genetics / Q000627:therapeutic use; D016685:Mitomycin / Q000627:therapeutic use; D011948:Receptors, Antigen, T-Cell; D011995:Recombination, Genetic; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation
D000922:Immunotoxins; D007376:Interleukin-2; D008222:Lymphokines; D011948:Receptors, Antigen, T-Cell; D016685:Mitomycin